Skip to content

High-risk Coronary Atherosclerosis in Subjects With Family History of Myocardial Infarction

High-risk Coronary Atherosclerosis in Subjects With Family History of Myocardial Infarction; the FAMILY Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07352111
Acronym
FAMILY
Enrollment
200
Registered
2026-01-20
Start date
2025-12-03
Completion date
2027-12-31
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Diease

Keywords

Cardiac CT, family history of CAD, atherosclerosis, primary prevention

Brief summary

The evidence of high-risk atherosclerosis at cardiac CT (CCT) may support aggressive primary prevention treatment, reducing the risk of future cardiovascular events. Family history of coronary artery disease (CAD) is a risk factor for cardiovascular events but limited data described the prevalence of coronary atherosclerosis in these patients. Aims of the FAMILY project are to explore the prevalence of high-risk coronary atherosclerosis among patients with family history of CAD, to explore whether CCT in this setting may to reclassify patients' vs standard of care and to explore correlations between genetic background and high risk and potentially unstable coronary atherosclerosis. A consecutive cohort of asymptomatic of patients with family history of CAD will be prospectively enrolled. A per-protocol CCT with advanced atherosclerosis analysis will be performed. At the time of CCT a blood sample will be collected for bio-humoral and genetic investigation. The prevalence of high risk atherosclerosis will be quantified, the reclassification rate of CCT vs clinical evaluation evaluated and the potential in vivo association between genetic profile and high risk atherosclerosis explored.

Interventions

DIAGNOSTIC_TESTCardiac CT

Cardiac CT with advance plaque evaluation will be performed

Sponsors

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* patients with postive family history of CAD

Exclusion criteria

* known cardiovascular diseases * any symptoms

Design outcomes

Primary

MeasureTime frameDescription
Risk reclassification3 yearsRisk reclassification rate will be evaluated

Countries

Italy

Contacts

CONTACTElena Cittera
direzionescientifica.ogsa@grupposandonato.it0039 02 83502227

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026